|
NL103316C
(en)
|
1956-02-13 |
1900-01-01 |
|
|
|
BE787580A
(en)
|
1971-08-13 |
1973-02-14 |
Hoechst Ag |
FURANNE DERIVATIVE PREPARATION PROCESS
|
|
BE787576A
(en)
|
1971-08-13 |
1973-02-14 |
Hoechst Ag |
BENZOFURANE DERIVATIVES AND THEIR USE AS OPTICAL BLASTERS
|
|
GB1409865A
(en)
|
1973-02-13 |
1975-10-15 |
Science Union & Cie |
Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
|
|
US4062858A
(en)
|
1976-12-22 |
1977-12-13 |
E. R. Squibb & Sons, Inc. |
Derivatives of 5,6-dihydrobenzo[5,6]cyclohepta[1,2-b]pyrazolo[4,3-e]pyridin-11(1H)-ones and 11(1H)-imines
|
|
GB1593417A
(en)
|
1976-12-22 |
1981-07-15 |
Squibb & Sons Inc |
Carbocyclic-fused pyrazolopyridine derivatives
|
|
DE2964427D1
(en)
|
1978-10-04 |
1983-02-03 |
Ciba Geigy Ag |
Process for the preparation of furanyl-benzazoles
|
|
DE2853765A1
(en)
|
1978-12-13 |
1980-06-26 |
Bayer Ag |
METHOD FOR PRODUCING BENZIMIDAZOLYLBENZOFURANES
|
|
DE2904829A1
(en)
|
1979-02-08 |
1980-08-14 |
Bayer Ag |
METHOD FOR PRODUCING BENZIMIDAZOLYLBENZOFURANE
|
|
ZA803880B
(en)
|
1979-06-29 |
1982-02-24 |
Wellcome Found |
Pharmaceutical ethers,preparation,use and intermediates therefor and their preparation
|
|
ZA818741B
(en)
|
1980-12-18 |
1983-07-27 |
Wellcome Found |
Pharmaceutical compounds,preparation,use and intermediates therefor and their preparation
|
|
JPS5929667A
(en)
|
1982-08-13 |
1984-02-16 |
Otsuka Pharmaceut Co Ltd |
Carbostyryl derivative
|
|
US4478834A
(en)
|
1983-02-11 |
1984-10-23 |
Usv Pharmaceutical Corporation |
Dihydropyridines and their use in the treatment of asthma
|
|
GB8402740D0
(en)
|
1984-02-02 |
1984-03-07 |
Scras |
Furo-(3 4-c)-pyridine derivatives
|
|
JPS6140236A
(en)
|
1984-08-02 |
1986-02-26 |
Yamanouchi Pharmaceut Co Ltd |
Hydroquinone derivative
|
|
DE3431004A1
(en)
|
1984-08-23 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
NEW 3-PYRIDYL COMPOUNDS AND METHOD FOR THEIR PRODUCTION
|
|
DD226590A1
(en)
|
1984-09-07 |
1985-08-28 |
Univ Leipzig |
MEANS FOR PHAGENHEMMUNG IN MICROBIAL PRODUCTION PROCESSES
|
|
GB8603475D0
(en)
|
1986-02-12 |
1986-03-19 |
Glaxo Group Ltd |
Chemical compounds
|
|
DK111387A
(en)
|
1986-03-05 |
1987-09-06 |
Otsuka Pharma Co Ltd |
CARBOSTYRIL DERIVATIVES AND SALTS THEREOF, MEDICINE CONTAINING SUCH DERIVATIVES AND PROCEDURES FOR THE PREPARATION OF THE DERIVATIVES
|
|
US4831041A
(en)
|
1986-11-26 |
1989-05-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Imidazopyridine compounds and processes for preparation thereof
|
|
AU598093B2
(en)
|
1987-02-07 |
1990-06-14 |
Wellcome Foundation Limited, The |
Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
|
|
DD258226A1
(en)
|
1987-03-05 |
1988-07-13 |
Fahlberg List Veb |
PROCESS FOR PRODUCING AROXYMETHYLCHINOXALINES
|
|
JPH07121937B2
(en)
|
1987-03-18 |
1995-12-25 |
大塚製薬株式会社 |
Carbostyril derivative
|
|
JPS63258463A
(en)
|
1987-04-14 |
1988-10-25 |
Kumiai Chem Ind Co Ltd |
2-phenoxypyrimidine derivatives and herbicides
|
|
GB8711802D0
(en)
|
1987-05-19 |
1987-06-24 |
Fujisawa Pharmaceutical Co |
Dithioacetal compounds
|
|
GB8718940D0
(en)
|
1987-08-11 |
1987-09-16 |
Glaxo Group Ltd |
Chemical compounds
|
|
US4920131A
(en)
|
1987-11-03 |
1990-04-24 |
Rorer Pharmaceutical Corp. |
Quinoline derivatives and use thereof as antagonists of leukotriene D4
|
|
JP2650038B2
(en)
|
1988-01-27 |
1997-09-03 |
サントリー株式会社 |
Pyrrolitidine compounds and uses thereof
|
|
JPH01305081A
(en)
|
1988-04-04 |
1989-12-08 |
E R Squibb & Sons Inc |
3-acylamino-1-((((substituted sulfonyl)amino) carbonyl)amino)-2-azetinones
|
|
US4952574A
(en)
|
1988-09-26 |
1990-08-28 |
Riker Laboratories, Inc. |
Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides
|
|
IE81170B1
(en)
|
1988-10-21 |
2000-05-31 |
Zeneca Ltd |
Pyridine derivatives
|
|
DD276479A1
(en)
|
1988-10-26 |
1990-02-28 |
Fahlberg List Veb |
PROCESS FOR THE PREPARATION OF BENZO / B / FUR-2-YLCHINOXALINES
|
|
DD276480A1
(en)
|
1988-10-26 |
1990-02-28 |
Fahlberg List Veb |
PROCESS FOR THE PREPARATION OF NAPHTHO / 2,1-B / FUR-2-YLCHINOXALINES
|
|
US5236917A
(en)
|
1989-05-04 |
1993-08-17 |
Sterling Winthrop Inc. |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
|
|
IT1230859B
(en)
|
1989-06-05 |
1991-11-08 |
Corvi Camillo Spa |
2 ALCHYLYLPHENOLS SUBSTITUTED FOR ANTI-INFLAMMATORY ACTION, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
|
|
EP0453210A3
(en)
|
1990-04-19 |
1993-01-13 |
Imperial Chemical Industries Plc |
Pyridine derivatives
|
|
NZ238576A
(en)
|
1990-06-18 |
1994-12-22 |
Merck & Co Inc |
Pyridinone derivatives, preparation and pharmaceutical compositions thereof
|
|
KR100196559B1
(en)
|
1990-06-19 |
1999-06-15 |
기따사또 이찌로 |
Pyridine derivatives with angiotensin ii antagonism
|
|
NL9001752A
(en)
|
1990-08-02 |
1992-03-02 |
Cedona Pharm Bv |
NEW 1,4-DIHYDROPYRIDINE DERIVATIVES.
|
|
IL99731A0
(en)
|
1990-10-18 |
1992-08-18 |
Merck & Co Inc |
Hydroxylated pyridine derivatives,their preparation and pharmaceutical compositions containing them
|
|
US5403816A
(en)
|
1990-10-25 |
1995-04-04 |
Kumiai Chemical Industry Co., Ltd. |
Picolinic acid derivative and herbicidal composition
|
|
JPH05301872A
(en)
|
1992-04-23 |
1993-11-16 |
Kumiai Chem Ind Co Ltd |
Picolinic acid derivative and herbicide
|
|
EP0498380A1
(en)
|
1991-02-08 |
1992-08-12 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Complexing agents
|
|
JPH0641118A
(en)
|
1991-05-31 |
1994-02-15 |
Kumiai Chem Ind Co Ltd |
Picolinic acid derivative and herbicide
|
|
US5185251A
(en)
|
1991-06-07 |
1993-02-09 |
Merck & Co., Inc. |
Microbial transformation of a substituted pyridinone using actinoplanacete sp. MA 6559
|
|
JP2600644B2
(en)
|
1991-08-16 |
1997-04-16 |
藤沢薬品工業株式会社 |
Thiazolyl benzofuran derivative
|
|
FR2680512B1
(en)
|
1991-08-20 |
1995-01-20 |
Adir |
NOVEL 2,4-THIAZOLIDINEDIONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
|
|
US5202243A
(en)
|
1991-10-04 |
1993-04-13 |
Merck & Co., Inc. |
Method of hydroxylating 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-2-(1H)-pyridinone by incubation with liver slices
|
|
GB9203798D0
(en)
|
1992-02-21 |
1992-04-08 |
Fujisawa Pharmaceutical Co |
Quinolylbenzofuran derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
|
|
WO1994001406A1
(en)
|
1992-07-01 |
1994-01-20 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Contrast agents for mr diagnosis
|
|
US5290941A
(en)
|
1992-10-14 |
1994-03-01 |
Merck & Co., Inc. |
Facile condensation of methylbenzoxazoles with aromatic aldehydes
|
|
US5521202A
(en)
|
1993-04-07 |
1996-05-28 |
Taiho Pharmaceutical Co., Ltd. |
Thiazolidine derivatives and pharmaceutical compositions containing the same
|
|
DE4318550A1
(en)
|
1993-06-04 |
1994-12-08 |
Boehringer Mannheim Gmbh |
Arylidene-4-oxo-2-thioxo-3-thiazolidinecarboxylic acids, process for their preparation and pharmaceutical compositions containing them
|
|
AU672699B2
(en)
|
1993-06-30 |
1996-10-10 |
Sankyo Company Limited |
Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
|
|
JPH0725882A
(en)
|
1993-07-07 |
1995-01-27 |
Res Dev Corp Of Japan |
INTERMEDIATE FOR PRODUCING ACROMELIC ACID B AND E AND METHOD FOR PRODUCING THE SAME
|
|
DK0637586T3
(en)
|
1993-08-05 |
1999-12-06 |
Hoechst Marion Roussel Inc |
2- (Piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl) -benzofuran-7-carbamate derivatives, their preparation and use
|
|
EP0640609A1
(en)
|
1993-08-24 |
1995-03-01 |
Ono Pharmaceutical Co., Ltd. |
Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species
|
|
US5840900A
(en)
|
1993-10-20 |
1998-11-24 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
US5965566A
(en)
|
1993-10-20 |
1999-10-12 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
US5880131A
(en)
|
1993-10-20 |
1999-03-09 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
US5605976A
(en)
|
1995-05-15 |
1997-02-25 |
Enzon, Inc. |
Method of preparing polyalkylene oxide carboxylic acids
|
|
WO1995014015A1
(en)
|
1993-11-19 |
1995-05-26 |
Ciba-Geigy Ag |
Benzothiophene derivatives possessing a methoxyimino substituent as microbicides
|
|
EP0658559A1
(en)
|
1993-12-14 |
1995-06-21 |
Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. |
Thienothiazin derivatives, process for their preparation and their use as 5-dipoxygenase and cyclooxygenase inhibitors
|
|
JPH09508906A
(en)
|
1994-02-14 |
1997-09-09 |
メレル ファーマスーティカルズ インコーポレーテッド |
Novel mercaptoacetylamide 1,3,4,5-tetrahydrobenzo [C] azepin-3-one disulfide derivatives useful as enkephalinase and ACE inhibitors
|
|
GB9420557D0
(en)
|
1994-10-12 |
1994-11-30 |
Zeneca Ltd |
Aromatic compounds
|
|
DE4442050A1
(en)
|
1994-11-25 |
1996-05-30 |
Hoechst Ag |
Heterospiro compounds and their use as electroluminescent materials
|
|
US5650408A
(en)
|
1995-06-07 |
1997-07-22 |
Karanewsky; Donald S. |
Thiazolo benzazepine containing dual action inhibitors
|
|
TW434240B
(en)
|
1995-06-20 |
2001-05-16 |
Zeneca Ltd |
Aromatic compounds, preparation thereof and pharmaceutical composition comprising same
|
|
JP3895404B2
(en)
|
1996-05-17 |
2007-03-22 |
興和株式会社 |
Chalcone derivative and pharmaceutical containing the same
|
|
EP0923580A1
(en)
|
1996-07-26 |
1999-06-23 |
Dr. Reddy's Research Foundation |
Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
|
|
EP0922028A1
(en)
|
1996-08-26 |
1999-06-16 |
Genetics Institute, Inc. |
Inhibitors of phospholipase enzymes
|
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
|
AU4136197A
(en)
|
1996-09-09 |
1998-03-26 |
Kyowa Hakko Kogyo Co. Ltd. |
Pyrrolocarbazole derivatives
|
|
EP0941222A2
(en)
|
1996-11-12 |
1999-09-15 |
Novartis AG |
Pyrazole derivatives useful as herbicides
|
|
US6043389A
(en)
|
1997-03-11 |
2000-03-28 |
Mor Research Applications, Ltd. |
Hydroxy and ether-containing oxyalkylene esters and uses thereof
|
|
US5760232A
(en)
|
1997-06-16 |
1998-06-02 |
Schering Corporation |
Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
|
|
US6214817B1
(en)
|
1997-06-20 |
2001-04-10 |
Monsanto Company |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
|
|
US6011042A
(en)
|
1997-10-10 |
2000-01-04 |
Enzon, Inc. |
Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
|
|
US6111107A
(en)
|
1997-11-20 |
2000-08-29 |
Enzon, Inc. |
High yield method for stereoselective acylation of tertiary alcohols
|
|
KR100349385B1
(en)
|
1997-12-12 |
2002-08-24 |
유로-셀티크 소시에떼 아노뉨 |
3-substituted adenines via 2-thioxanthines
|
|
EA200000873A1
(en)
|
1998-02-25 |
2001-04-23 |
Дженетикс Инститьют, Инк. |
Phospholipase A Inhibitors
|
|
CA2319493A1
(en)
|
1998-03-18 |
1999-09-23 |
Regine Bohacek |
Heterocyclic signal transduction inhibitors, compositions containing them
|
|
US6214879B1
(en)
|
1998-03-24 |
2001-04-10 |
Virginia Commonwealth University |
Allosteric inhibitors of pyruvate kinase
|
|
US6153655A
(en)
|
1998-04-17 |
2000-11-28 |
Enzon, Inc. |
Terminally-branched polymeric linkers and polymeric conjugates containing the same
|
|
GB9810860D0
(en)
|
1998-05-20 |
1998-07-22 |
Hoechst Schering Agrevo Gmbh |
Substituted pyridine and pyrimidines, processes for their preparation and their use as pesticides
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
TR200100189T2
(en)
|
1998-06-04 |
2001-05-21 |
Abbott Laboratories |
Anti-inflammatory compounds against cell adhesion
|
|
GB9818627D0
(en)
|
1998-08-26 |
1998-10-21 |
Glaxo Group Ltd |
Improvements in dva vaccination
|
|
GB9823871D0
(en)
|
1998-10-30 |
1998-12-23 |
Pharmacia & Upjohn Spa |
2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
|
|
US20030060425A1
(en)
|
1998-11-24 |
2003-03-27 |
Ahlem Clarence N. |
Immune modulation method using steroid compounds
|
|
WO2000035858A1
(en)
|
1998-12-14 |
2000-06-22 |
F. Hoffmann-La Roche Ag |
Phenylglycine derivatives
|
|
AU1836900A
(en)
|
1998-12-31 |
2000-07-24 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
|
US6544980B2
(en)
|
1998-12-31 |
2003-04-08 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
|
MXPA01009733A
(en)
|
1999-03-31 |
2002-11-04 |
Basf Ag |
Pyridine-2,3-dicarboxylic acid diamides.
|
|
US6251927B1
(en)
|
1999-04-20 |
2001-06-26 |
Medinox, Inc. |
Methods for treatment of sickle cell anemia
|
|
MXPA01011502A
(en)
|
1999-05-14 |
2003-08-20 |
Boehringer Ingelheim Pharma |
Enzyme-activated anti-tumor prodrug compounds.
|
|
US6184228B1
(en)
|
1999-05-25 |
2001-02-06 |
Anadys Pharmaceuticals, Inc. |
Anti-sickling agents: selection methods and effective compounds
|
|
WO2000075145A1
(en)
|
1999-06-03 |
2000-12-14 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
AUPQ105499A0
(en)
|
1999-06-18 |
1999-07-08 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
|
IL147327A0
(en)
|
1999-06-28 |
2002-08-14 |
Janssen Pharmaceutica Nv |
Respiratory syncytial virus replication inhibitors
|
|
JP4206212B2
(en)
|
1999-09-28 |
2009-01-07 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
Quinuclidine compound and medicament containing it as an active ingredient
|
|
NZ530450A
(en)
|
1999-11-05 |
2004-06-25 |
Emisphere Tech Inc |
Phenoxy carboxylic acid compounds and compositions for delivering active agents
|
|
AUPQ407699A0
(en)
|
1999-11-16 |
1999-12-09 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
DE60006340T2
(en)
|
1999-11-29 |
2004-09-09 |
F. Hoffmann-La Roche Ag |
2- (3,5-Bis-trifluoromethyl-phenyl) -N-methyl-N- (6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl) -isobutyramide
|
|
MXPA02006660A
(en)
|
2000-01-07 |
2002-12-13 |
Transform Pharmaceuticals Inc |
Highthroughput formation, identification, and analysis of diverse solidforms.
|
|
AU2001230537A1
(en)
|
2000-02-01 |
2001-08-14 |
Daiichi Pharmaceutical Co., Ltd. |
Pyridoxazine derivatives
|
|
US6506755B2
(en)
|
2000-02-03 |
2003-01-14 |
Hoffmann-La Roche Inc. |
Thiazolidinecarboxyl acids
|
|
AUPQ585000A0
(en)
|
2000-02-28 |
2000-03-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
AU2001245823A1
(en)
|
2000-03-17 |
2001-10-03 |
Corixa Corporation |
Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
|
|
AUPQ841300A0
(en)
|
2000-06-27 |
2000-07-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New aminoalcohol derivatives
|
|
SI1303490T1
(en)
|
2000-07-14 |
2008-10-31 |
Hoffmann La Roche |
N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
|
|
WO2002009723A2
(en)
|
2000-08-01 |
2002-02-07 |
Gmp Companies, Inc. |
Ammonium salts of hemoglobin allosteric effectors, and uses thereof
|
|
US6653313B2
(en)
|
2000-08-10 |
2003-11-25 |
Warner-Lambert Company Llc |
1,4-dihydropyridine compounds as bradykinin antagonists
|
|
JP4272338B2
(en)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
Pyridine derivatives
|
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
AU2002224266B2
(en)
|
2000-11-20 |
2007-05-24 |
Biovitrum Ab |
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
|
|
WO2002051849A1
(en)
|
2000-12-26 |
2002-07-04 |
Daiichi Pharmaceutical Co., Ltd. |
Cdk4 inhibitors
|
|
US7238716B2
(en)
|
2000-12-28 |
2007-07-03 |
Takeda Pharmaceuticals Company Limited |
Alkanoic acid derivatives process for their production and use thereof
|
|
GB0102595D0
(en)
|
2001-02-01 |
2001-03-21 |
Virk Kuldip |
Smart solar
|
|
US20030022923A1
(en)
|
2001-03-01 |
2003-01-30 |
Medinox, Inc. |
Methods for treatment of sickle cell anemia
|
|
US6627646B2
(en)
*
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
|
EP1435894A4
(en)
|
2001-07-23 |
2005-07-06 |
Galileo Pharmaceuticals Inc |
CYTOPROTECTIVE COMPOUNDS, METHODS AND PHARMACEUTICAL AND COSMETIC FORMULATIONS
|
|
JP2003075970A
(en)
|
2001-08-31 |
2003-03-12 |
Konica Corp |
Silver halide color photographic sensitive material, color photographic sensitive material, image forming method for the same and method for creating digital image information
|
|
KR100467313B1
(en)
|
2001-11-22 |
2005-01-24 |
한국전자통신연구원 |
Red organic electroluminescent compounds, method for synthesizing the same and electroluminescent devices
|
|
GB0128499D0
(en)
|
2001-11-28 |
2002-01-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
AU2002360763A1
(en)
|
2001-12-19 |
2003-07-09 |
Atherogenics, Inc. |
Chalcone derivatives and their use to treat diseases
|
|
US20030190333A1
(en)
|
2002-02-04 |
2003-10-09 |
Corixa Corporation |
Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
|
|
EP1542704A1
(en)
|
2002-04-18 |
2005-06-22 |
Stephen H. Embury |
Method and composition for preventing pain in sickle cell patients
|
|
US6608076B1
(en)
|
2002-05-16 |
2003-08-19 |
Enzon, Inc. |
Camptothecin derivatives and polymeric conjugates thereof
|
|
GB0212785D0
(en)
|
2002-05-31 |
2002-07-10 |
Glaxo Group Ltd |
Compounds
|
|
US20060074119A1
(en)
|
2002-08-08 |
2006-04-06 |
Andrews Clarence W Iii |
Thiophene compounds
|
|
JPWO2004018430A1
(en)
|
2002-08-23 |
2005-12-08 |
麒麟麦酒株式会社 |
Compound having TGFβ inhibitory activity and pharmaceutical composition comprising the same
|
|
AU2003262023A1
(en)
|
2002-09-10 |
2004-04-30 |
Takeda Pharmaceutical Company Limited |
Five-membered heterocyclic compounds
|
|
WO2004050030A2
(en)
|
2002-12-04 |
2004-06-17 |
Virginia Commonwealth University |
Anti-sickling agents
|
|
WO2004056727A2
(en)
|
2002-12-19 |
2004-07-08 |
Atherogenics, Inc. |
Process of making chalcone derivatives
|
|
JP4679155B2
(en)
|
2002-12-25 |
2011-04-27 |
キッセイ薬品工業株式会社 |
Nitrogen-containing heterocyclic derivative, pharmaceutical composition containing the same, and pharmaceutical use thereof
|
|
WO2004073675A1
(en)
|
2003-02-24 |
2004-09-02 |
Randolph Riemschneider |
Cosmetic composition with a whitening effect, method for the production and use thereof
|
|
US20040186077A1
(en)
|
2003-03-17 |
2004-09-23 |
Medicure International Inc. |
Novel heteroaryl phosphonates as cardioprotective agents
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
EP1613613B1
(en)
|
2003-04-11 |
2021-06-02 |
Genzyme Corporation |
Cxcr4 chemokine receptor binding compounds
|
|
CA2526204A1
(en)
|
2003-06-12 |
2004-12-23 |
Novo Nordisk A/S |
Pyridinyl carbamates as hormone-sensitive lipase inhibitors
|
|
US7259164B2
(en)
|
2003-08-11 |
2007-08-21 |
Cgi Pharmaceuticals, Inc. |
Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
|
|
US7411083B2
(en)
|
2003-09-25 |
2008-08-12 |
Wyeth |
Substituted acetic acid derivatives
|
|
BRPI0416283A
(en)
|
2003-11-05 |
2007-01-23 |
Hoffmann La Roche |
compounds, process for the manufacture of compounds, pharmaceutical composition, method for treating and / or preventing diseases that are modulated by ppar (delta) and / or ppar (alpha) agonists and use of these compounds
|
|
JP2007513082A
(en)
|
2003-11-10 |
2007-05-24 |
シエーリング アクチエンゲゼルシャフト |
Benzyl ether amine compounds useful as CCR-5 antagonists
|
|
KR20060109979A
(en)
|
2003-12-02 |
2006-10-23 |
셀진 코포레이션 |
Methods and compositions for the treatment and management of hemochromatosis and anemia
|
|
US7378439B2
(en)
|
2004-01-20 |
2008-05-27 |
Usv, Ltd. |
Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
|
|
EP1713773A4
(en)
|
2004-01-30 |
2009-09-23 |
Merck & Co Inc |
N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integrase inhibitors
|
|
GB0403038D0
(en)
|
2004-02-11 |
2004-03-17 |
Novartis Ag |
Organic compounds
|
|
JP2007528379A
(en)
|
2004-03-09 |
2007-10-11 |
イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー |
HIV integrase inhibitor
|
|
WO2005086951A2
(en)
|
2004-03-10 |
2005-09-22 |
Threshold Pharmaceuticals, Inc. |
Hypoxia-activated anti-cancer agents
|
|
DE102004015226B3
(en)
|
2004-03-24 |
2005-08-25 |
Siemens Ag |
Plasma cleaning method suitable for interior surfaces of e.g. bulbs for discharge lamps, forms back pressure and ignites plasma only inside bulb
|
|
EP1745012A4
(en)
|
2004-04-22 |
2010-11-03 |
Univ Virginia Commonwealth |
ALLOSTERIC HEMOGLOBIN MODIFIER COMPOSITIONS AND METHODS OF MAKING SAME
|
|
TW200606133A
(en)
|
2004-06-30 |
2006-02-16 |
Sankyo Co |
Substituted benzene compounds
|
|
TW200606129A
(en)
|
2004-07-26 |
2006-02-16 |
Chugai Pharmaceutical Co Ltd |
Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
US7812037B2
(en)
|
2004-10-28 |
2010-10-12 |
Medicure International, Inc. |
Dual antiplatelet/anticoagulant pyridoxine analogs
|
|
WO2006065204A1
(en)
|
2004-12-14 |
2006-06-22 |
Astrazeneca Ab |
Substituted aminopyridines and uses thereof
|
|
US7968574B2
(en)
|
2004-12-28 |
2011-06-28 |
Kinex Pharmaceuticals, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
|
WO2006088173A1
(en)
|
2005-02-21 |
2006-08-24 |
Shionogi & Co., Ltd. |
Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
|
|
US7763657B2
(en)
|
2005-03-19 |
2010-07-27 |
Amorepacific Corporation |
Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
|
|
US7829585B2
(en)
|
2005-03-30 |
2010-11-09 |
Eisai R&D Management Co., Ltd. |
Antifungal agent containing pyridine derivative
|
|
GB0506677D0
(en)
|
2005-04-01 |
2005-05-11 |
Btg Int Ltd |
Iron modulators
|
|
SI3045206T1
(en)
|
2005-04-28 |
2018-07-31 |
Viiv Healthcare Company |
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
|
|
DE102005025989A1
(en)
|
2005-06-07 |
2007-01-11 |
Bayer Cropscience Ag |
carboxamides
|
|
JP2006342115A
(en)
|
2005-06-10 |
2006-12-21 |
Shionogi & Co Ltd |
Polycyclic compound having hiv integrase inhibition activity
|
|
BRPI0613505A2
(en)
|
2005-06-30 |
2011-01-11 |
Prosidion Ltd |
gpcr agonists
|
|
CN100562514C
(en)
|
2005-07-22 |
2009-11-25 |
中国科学院上海药物研究所 |
A class of substituted propionamide derivatives, its preparation method and use
|
|
GB0516270D0
(en)
|
2005-08-08 |
2005-09-14 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2007047204A1
(en)
|
2005-10-11 |
2007-04-26 |
University Of Pittsburgh |
Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins
|
|
AU2006307101A1
(en)
|
2005-10-27 |
2007-05-03 |
Shionogi & Co., Ltd. |
Polycyclic carbamoylpyridone derivative having inhibitory activity on HIV integrase
|
|
JP2009515997A
(en)
|
2005-11-18 |
2009-04-16 |
タケダ サン ディエゴ インコーポレイテッド |
Glucokinase activator
|
|
EP1976851A2
(en)
|
2006-01-17 |
2008-10-08 |
Neurocrine Biosciences, Inc. |
Phenoxy-substituted pyrimidines as adenosine receptor antagonists
|
|
WO2007095495A2
(en)
|
2006-02-13 |
2007-08-23 |
Pharmacopeia, Inc. |
Benzodiazepine gcnf modulators for stem cell modulation
|
|
RU2318818C1
(en)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Azaheterocycles, combinatory library, focused library, pharmaceutical composition and method for preparing (variants)
|
|
GB0614586D0
(en)
|
2006-07-22 |
2006-08-30 |
Pliva Istrazivacki Inst D O O |
Pharmaceutical Formulation
|
|
CN101113148A
(en)
|
2006-07-26 |
2008-01-30 |
中国海洋大学 |
Dioxypiperazine compounds and their preparation method and use
|
|
KR101410318B1
(en)
|
2006-07-27 |
2014-06-27 |
(주)아모레퍼시픽 |
Novel compound as a vanilloid receptor antagonist, an isomer thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same
|
|
TW200817424A
(en)
|
2006-08-04 |
2008-04-16 |
Daiichi Sankyo Co Ltd |
Benzylphenyl glucopyranoside derivatives
|
|
TWI389895B
(en)
|
2006-08-21 |
2013-03-21 |
Infinity Discovery Inc |
Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
|
|
CN101506143B
(en)
|
2006-09-03 |
2013-06-05 |
于崇曦 |
Positively charged water-soluble prodrugs of acetaminophen and related compounds with fast skin penetration rate
|
|
EP2079739A2
(en)
|
2006-10-04 |
2009-07-22 |
Pfizer Products Inc. |
Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
|
|
US8119681B2
(en)
|
2006-10-23 |
2012-02-21 |
Merck Sharp & Dohme Corp. |
2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta [ƒ]indazole-5-YL]ethyl phenyl derivatives as glucocorticoid receptor ligands
|
|
WO2008066145A1
(en)
|
2006-11-30 |
2008-06-05 |
R-Tech Ueno, Ltd. |
Thiazole derivative and use thereof as vap-1 inhibitor
|
|
WO2008066151A1
(en)
|
2006-11-30 |
2008-06-05 |
Tokyo Institute Of Technology |
Novel curcumin derivative
|
|
FR2909379B1
(en)
|
2006-11-30 |
2009-01-16 |
Servier Lab |
NOVEL HETEROCYCLIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.
|
|
UA102514C2
(en)
|
2007-02-22 |
2013-07-25 |
Сингента Партисипейшнс Аг |
Iminipyridine derivatives, intermediate, method for controlling or preventing infestation of useful plants by phytopathogenic microorganisms and a composition based on iminipyridine
|
|
TWI407960B
(en)
|
2007-03-23 |
2013-09-11 |
Jerini Ag |
Small molecule bradykinin b2 receptor modulators
|
|
EP2149545B1
(en)
|
2007-05-22 |
2016-10-05 |
Sumitomo Chemical Company, Limited |
Method for producing benzaldehyde compound
|
|
WO2009001214A2
(en)
|
2007-06-28 |
2008-12-31 |
Pfizer Products Inc. |
Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
|
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
|
RU2440989C2
(en)
|
2007-07-17 |
2012-01-27 |
Ф.Хоффманн-Ля Рош Аг |
11β-HYDROXYSTEROID DIHYDROGENASE INHIBITORS
|
|
AU2008280135B2
(en)
|
2007-07-26 |
2012-02-23 |
Novartis Ag |
Organic compounds
|
|
TW200918521A
(en)
|
2007-08-31 |
2009-05-01 |
Astrazeneca Ab |
Heterocyclic amides and methods of use thereof
|
|
JP5456681B2
(en)
|
2007-10-17 |
2014-04-02 |
ノバルティス アーゲー |
Imidazo [1,2-a] pyridine derivatives useful as ALK inhibitors
|
|
PL2227467T3
(en)
|
2007-12-04 |
2015-05-29 |
Hoffmann La Roche |
Isoxazolo-pyridine derivatives
|
|
US7776875B2
(en)
|
2007-12-19 |
2010-08-17 |
Hoffman-La Roche Inc. |
Spiroindolinone derivatives
|
|
JP2009203230A
(en)
|
2008-01-31 |
2009-09-10 |
Daiichi Sankyo Co Ltd |
Pharmaceutical composition containing benzyl phenyl glucopyranoside derivative
|
|
DK2241546T3
(en)
|
2008-02-14 |
2017-11-13 |
Sumitomo Chemical Co |
PROCEDURE FOR PREPARING A BENZALDEHYD COMPOUND
|
|
US8268834B2
(en)
*
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
US8633245B2
(en)
|
2008-04-11 |
2014-01-21 |
Institute Of Medicinal Molecular Design, Inc. |
PAI-1 inhibitor
|
|
CA2720096A1
(en)
|
2008-04-11 |
2009-10-15 |
Institute Of Medicinal Molecular Design, Inc. |
Pai-1 inhibitor
|
|
JP2011136906A
(en)
|
2008-04-18 |
2011-07-14 |
Otsuka Pharmaceut Co Ltd |
Heterocyclic compound
|
|
US8119647B2
(en)
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
|
WO2009136889A1
(en)
|
2008-05-08 |
2009-11-12 |
Nova Southeastern University |
Specific inhibitors for vascular endothelial growth factor receptors
|
|
EP2300433A4
(en)
|
2008-06-04 |
2012-03-07 |
Ambrilia Biopharma Inc |
Hiv integrase inhibitors from pyridoxine
|
|
DE102008027574A1
(en)
|
2008-06-10 |
2009-12-17 |
Merck Patent Gmbh |
New pyrrolidine derivatives as MetAP-2 inhibitors
|
|
JP5314330B2
(en)
|
2008-06-16 |
2013-10-16 |
住友化学株式会社 |
Process for producing 2- (aryloxymethyl) benzaldehyde and its intermediate
|
|
GB0811451D0
(en)
|
2008-06-20 |
2008-07-30 |
Syngenta Participations Ag |
Novel microbiocides
|
|
AR073304A1
(en)
|
2008-09-22 |
2010-10-28 |
Jerini Ag |
MODULATORS OF THE BRADIQUININE B2 RECEPTOR OF SMALL MOLECULA
|
|
JP2012508692A
(en)
|
2008-11-12 |
2012-04-12 |
シェーリング コーポレイション |
Inhibitors of fatty acid binding protein (FABP)
|
|
TW201033201A
(en)
|
2009-02-19 |
2010-09-16 |
Hoffmann La Roche |
Isoxazole-isoxazole and isoxazole-isothiazole derivatives
|
|
SI2732818T1
(en)
|
2009-03-31 |
2017-12-29 |
Ligand Pharmaceuticals Inc. |
A biphenylsulfonamide endothelin and angiotensin ii receptor antagonist to treat glomerulosclerosis
|
|
US8367654B2
(en)
|
2009-05-08 |
2013-02-05 |
Tetraphase Pharmaceuticals, Inc. |
8-AZA tetracycline compounds
|
|
WO2011024869A1
(en)
|
2009-08-26 |
2011-03-03 |
武田薬品工業株式会社 |
Fused heterocyclic ring derivative and use thereof
|
|
JPWO2011025006A1
(en)
|
2009-08-31 |
2013-01-31 |
日本ケミファ株式会社 |
GPR119 agonist
|
|
WO2011033045A1
(en)
|
2009-09-21 |
2011-03-24 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
EP4066821A1
(en)
|
2009-11-09 |
2022-10-05 |
Wyeth LLC |
Tablet formulations of neratinib maleate
|
|
TW201139406A
(en)
|
2010-01-14 |
2011-11-16 |
Glaxo Group Ltd |
Voltage-gated sodium channel blockers
|
|
KR101698153B1
(en)
|
2010-04-26 |
2017-01-23 |
광주과학기술원 |
Novel pyridine carboxylic acid compound as a P2X1 and P2X3 receptor antagonist, the preparation method thereof and a composition containing the same
|
|
CN102232949A
(en)
|
2010-04-27 |
2011-11-09 |
孙远 |
Drug dissolution increasing composition and preparation method thereof
|
|
TWI535442B
(en)
|
2010-05-10 |
2016-06-01 |
Kyowa Hakko Kirin Co Ltd |
A nitrogen-containing heterocyclic compound having an action of inhibiting the production of canine erythritine
|
|
WO2011156473A1
(en)
*
|
2010-06-09 |
2011-12-15 |
Abbott Laboratories |
Crystalline forms of kinase inhibitors
|
|
US20120122928A1
(en)
|
2010-08-11 |
2012-05-17 |
Bayer Cropscience Ag |
Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
|
|
CN102116772B
(en)
|
2010-09-28 |
2013-08-28 |
上海大学 |
Method for screening dihydrochalcone compound
|
|
CA2823166C
(en)
|
2010-12-27 |
2019-04-09 |
Takeda Pharmaceutical Company Limited |
Orally disintegrating tablet
|
|
EP2694514A2
(en)
|
2011-04-06 |
2014-02-12 |
Teva Pharmaceutical Industries Ltd. |
New intermediates and processes for preparing ticagrelor
|
|
EP2698368B1
(en)
|
2011-04-11 |
2018-02-14 |
Green Tech Co., Ltd. |
Novel pyrazole derivative
|
|
CN102952062B
(en)
|
2011-08-12 |
2016-06-08 |
中国医学科学院医药生物技术研究所 |
Replace benzo-heterocycle compound and its preparation method and application
|
|
CN103857397B
(en)
*
|
2011-09-15 |
2016-08-17 |
德莫科斯公司 |
Noribogaine salt non-solvent compound
|
|
US20140308260A1
(en)
|
2011-10-07 |
2014-10-16 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
|
PL2797416T3
(en)
|
2011-12-28 |
2017-12-29 |
Global Blood Therapeutics, Inc. |
Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
ES2790358T3
(en)
|
2011-12-28 |
2020-10-27 |
Global Blood Therapeutics Inc |
Substituted Heteroaryl Aldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
|
|
CN104884442B
(en)
|
2012-12-27 |
2016-11-02 |
住友化学株式会社 |
Tetrazolinone compounds and uses thereof
|
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
WO2014150276A1
(en)
|
2013-03-15 |
2014-09-25 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US9802900B2
(en)
|
2013-03-15 |
2017-10-31 |
Global Blood Therapeutics, Inc. |
Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
|
|
US9604999B2
(en)
|
2013-03-15 |
2017-03-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EP2968295A1
(en)
|
2013-03-15 |
2016-01-20 |
Global Blood Therapeutics, Inc. |
Compositions and methods for the modulation of hemoglobin (s)
|
|
US20140271591A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compositions and methods for the modulation of hemoglobin (s)
|
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EP2970184B1
(en)
|
2013-03-15 |
2018-12-05 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US20150057251A1
(en)
|
2013-08-26 |
2015-02-26 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EA201591426A1
(en)
|
2013-03-15 |
2016-02-29 |
Глобал Блад Терапьютикс, Инк. |
COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN
|
|
US20140274961A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
SG11201507351PA
(en)
|
2013-03-15 |
2015-10-29 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
|
WO2014145040A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
MX2015011445A
(en)
|
2013-03-15 |
2016-04-20 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin.
|
|
US20160206604A1
(en)
|
2013-08-26 |
2016-07-21 |
Global Blood Therapeutics, Inc. |
Formulations comprising wetting agents and compounds for the modulation of hemoglobin (s)
|
|
US20160207904A1
(en)
|
2013-08-27 |
2016-07-21 |
Global Blood Therapeutics, Inc. |
Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ansolvate salts
|
|
WO2015031285A1
(en)
|
2013-08-27 |
2015-03-05 |
Global Blood Therapeutics, Inc. |
Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ansolvate salts
|
|
US20150141465A1
(en)
|
2013-11-18 |
2015-05-21 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EA202092627A1
(en)
|
2013-11-18 |
2021-09-30 |
Глобал Блад Терапьютикс, Инк. |
COMPOUNDS AND THEIR APPLICATIONS FOR HEMOGLOBIN MODULATION
|
|
WO2015116061A1
(en)
|
2014-01-29 |
2015-08-06 |
Global Blood Therapeutics, Inc. |
1:1 adducts of sickle hemoglobin
|
|
US9248199B2
(en)
|
2014-01-29 |
2016-02-02 |
Global Blood Therapeutics, Inc. |
1:1 adducts of sickle hemoglobin
|
|
MX361810B
(en)
*
|
2014-02-07 |
2018-12-14 |
Global Blood Therapeutics Inc |
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-iso propyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde.
|
|
WO2016043849A2
(en)
|
2014-07-24 |
2016-03-24 |
Global Blood Therapeutics, Inc. |
Compounds for treating acute respiratory distress syndrome or a negative effect thereof
|
|
TWI544395B
(en)
|
2014-09-26 |
2016-08-01 |
義隆電子股份有限公司 |
Scanning method and device of single layer capacitive touch panel
|
|
MA41841A
(en)
|
2015-03-30 |
2018-02-06 |
Global Blood Therapeutics Inc |
ALDEHYDE COMPOUNDS FOR THE TREATMENT OF PULMONARY FIBROSIS, HYPOXIA, AND AUTOIMMUNE AND CONNECTIVE TISSUE DISEASES
|
|
MA43373A
(en)
|
2015-12-04 |
2018-10-10 |
Global Blood Therapeutics Inc |
DOSAGE REGIMES FOR 2-HYDROXY-6 - ((2- (1-ISOPROPYL-1H-PYRAZOL-5-YL) PYRIDIN-3-YL) METHOXY) BENZALDEHYDE
|
|
TWI663160B
(en)
|
2016-05-12 |
2019-06-21 |
全球血液治療公司 |
Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
|
|
TW202332423A
(en)
|
2016-10-12 |
2023-08-16 |
美商全球血液治療公司 |
Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
|
WO2020072377A1
(en)
|
2018-10-01 |
2020-04-09 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin for the treatment of sickle cell disease
|
|
SG11202104705RA
(en)
|
2018-11-19 |
2021-06-29 |
Global Blood Therapeutics Inc |
2-formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin
|